[ad_1]
Sunday, November 22, 2020
Regeneron’s Antibody Mix Works
Trump’s “miracle drug” gets emergency approval
Donald Trump survived his corona infection surprisingly fast in early October. He attributes his recovery to a “cure” he discovered by chance and which should soon be available to all. Now at least a first step has been taken.
The president of the United States, Donald Trump, praised the drug in the highest tones: the cocktail of antibodies for the treatment of Covid-19 has now received emergency approval in the US. The Food and Drug Administration of the United States. The United States (FDA) handed it over to the biotech company Regeneron on Saturday.
This means that the two-antibody cocktail can be used to treat patients twelve years of age and older who are at risk of developing severe Covid-19 symptoms. Patients who are in the hospital or need oxygen should not receive the drug. The FDA granted approval after a clinical trial of 799 adults with mild to moderate Covid-19 symptoms who were out of the hospital.
According to the New York Times, Regeneron received more than $ 500 million from the United States government to develop the drug. The government will provide the first 300,000 doses free of charge, but patients may have to pay health care facilities to have the drug administered, the drug maker said in a statement.
The antibody cocktail is supposed to prevent the virus from entering the cell. According to the company, the treatment leads to a reduction in viral load, that is, the amount of detectable virus, and a faster resolution of symptoms. The subjects who benefited the most from the study were those whose immune systems had not yet produced their own antibodies against the virus. The antibodies are directed against two regions of the spike protein on the surface of the Sars-CoV-2 virus. After his recovery from Covid-19, Trump announced treating the disease with Regeneron’s antibody cocktail in October. The drug is not a method of treatment, but a “cure” and a “miracle” that will soon be available to all, he had promised.
